Opexa Therapeutics, Inc.
Records under this name other than patents Opexa Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Opexa Therapeutics, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,972,848 | Isolation and Identification of Cross-Reactive T Cells Lapsed on the fee record Ended Jul 5, 2019 · Medium confidence | Lapsed on the fee record | Ended Jul 5, 2019 | Medium confidence |
| US 8,629,108 | Rheumatoid arthritis T cell vaccine Lapsed on the fee record Ended Jan 14, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jan 14, 2018 | From the USPTO record |